Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2691398015 | Nilotinib 200mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2694068015 | Nilotinib 200mg capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3469260018 | Nilotinib 200 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3469261019 | Product containing nilotinib 200 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3487396015 | Product containing nilotinib 200 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3570554016 | Product containing only nilotinib 200 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3570555015 | Product containing only nilotinib 200 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681150017 | Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681151018 | Nilotinib (as nilotinib hydrochloride monohydrate) 200 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3681152013 | Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Is a | Product containing nilotinib (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has active ingredient | Nilotinib (substance) | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has manufactured dose form | Oral capsule | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has active ingredient | Nilotinib hydrochloride monohydrate (substance) | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has active ingredient | Nilotinib hydrochloride monohydrate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has basis of strength substance (attribute) | Nilotinib (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 1 | |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has precise active ingredient | Nilotinib hydrochloride monohydrate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Is a | Product containing only nilotinib in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely nilotinib (as nilotinib hydrochloride monohydrate) 200 milligram/1 each conventional release oral capsule | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR